Cembre S.p.A. Ord
Cembre S.p.A. engages in the manufacture and sale of electrical connectors, cable accessories, and tools in Italy, the rest of Europe, and internationally. The company offers pre-insulated, terminal blocks and distribution blocks, non-insulated, rail contacts, and connections and grounding; crimping tools, cutting cables and wire ropes, stripping cables and wires, punching, pumps for hydraulic he… Read more
Cembre S.p.A. Ord (0DXU) - Net Assets
Latest net assets as of September 2021: €170.16 Million EUR
Based on the latest financial reports, Cembre S.p.A. Ord (0DXU) has net assets worth €170.16 Million EUR as of September 2021.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€234.43 Million) and total liabilities (€64.27 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €170.16 Million |
| % of Total Assets | 72.59% |
| Annual Growth Rate | 4.41% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 1.76 |
Cembre S.p.A. Ord - Net Assets Trend (2016–2020)
This chart illustrates how Cembre S.p.A. Ord's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cembre S.p.A. Ord (2016–2020)
The table below shows the annual net assets of Cembre S.p.A. Ord from 2016 to 2020.
| Year | Net Assets | Change |
|---|---|---|
| 2020-12-31 | €163.59 Million | +1.97% |
| 2019-12-31 | €160.43 Million | +4.94% |
| 2018-12-31 | €152.88 Million | +6.85% |
| 2017-12-31 | €143.07 Million | +3.96% |
| 2016-12-31 | €137.63 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cembre S.p.A. Ord's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 0.1% over the analyzed period, potentially due to dividend distributions or operating losses.
- The company has 3.0% of equity in treasury stock, representing shares repurchased from the open market.
Current Equity Component Breakdown (December 2020)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €117.93 Million | 72.09% |
| Common Stock | €8.84 Million | 5.40% |
| Treasury Stock | €4.90 Million | 2.99% |
| Other Components | €41.72 Million | 25.50% |
| Total Equity | €163.59 Million | 100.00% |
Cembre S.p.A. Ord Competitors by Market Cap
The table below lists competitors of Cembre S.p.A. Ord ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sirio Pharma
SHE:300791
|
$310.47 Million |
|
Shenzhen Rayitek Hi-Tech Film Co. Ltd. A
SHG:688323
|
$310.50 Million |
|
Flagship Communities Real Estate Investment Trust
PINK:MHCUF
|
$310.53 Million |
|
Dave & Buster’s Entertainment
NASDAQ:PLAY
|
$310.54 Million |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705
|
$310.45 Million |
|
China Aviation Oil (Singapore) Corporation Ltd
F:VZ8
|
$310.35 Million |
|
PT Citra Marga Nusaphala Persada Tbk
F:J7K
|
$310.34 Million |
|
Allgens Medical Technology Co. Ltd. A
SHG:688613
|
$310.34 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cembre S.p.A. Ord's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2019 to 2020, total equity changed from 160,426,000 to 163,589,000, a change of 3,163,000 (2.0%).
- Net income of 18,975,000 contributed positively to equity growth.
- Dividend payments of 15,048,000 reduced retained earnings.
- Share repurchases of 640,000 reduced equity.
Equity Change Factors (2019 to 2020)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €18.98 Million | +11.6% |
| Dividends Paid | €15.05 Million | -9.2% |
| Share Repurchases | €640.00K | -0.39% |
| Other Changes | €-124.00K | -0.08% |
| Total Change | €- | 1.97% |
Book Value vs Market Value Analysis
This analysis compares Cembre S.p.A. Ord's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Cembre S.p.A. Ord utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.60%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 13.84%
- • Asset Turnover: 0.62x
- • Equity Multiplier: 1.35x
- Recent ROE (11.60%) is below the historical average (13.64%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 12.30% | 13.81% | 0.75x | 1.19x | €3.16 Million |
| 2017 | 15.88% | 17.13% | 0.78x | 1.19x | €8.42 Million |
| 2018 | 14.87% | 15.78% | 0.74x | 1.27x | €7.45 Million |
| 2019 | 13.52% | 14.83% | 0.72x | 1.27x | €5.65 Million |
| 2020 | 11.60% | 13.84% | 0.62x | 1.35x | €2.62 Million |
Industry Comparison
This section compares Cembre S.p.A. Ord's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cembre S.p.A. Ord (0DXU) | €170.16 Million | 12.30% | 0.38x | $310.46 Million |
| Nyfosa AB (0A0K) | $3.48 Billion | 34.90% | 2.92x | $966.63 Million |
| Tethys Oil AB (0A1V) | $56.23 Million | 21.07% | 0.01x | $122.95 Million |
| High Templar Tech Limited (0A2T) | $11.29 Billion | 0.81% | 0.10x | $258.25 Million |
| Strategy Inc (0A7O) | $361.50 Million | 1.39% | 0.55x | $38.08 Billion |
| NACON SASU (0A9N) | $210.72 Million | 8.63% | 0.51x | $7.82 Million |
| Antin Infrastructure Partners (0AA5) | $32.26 Million | 152.50% | 1.23x | $545.92 Million |
| Truecaller AB Series B (0AA7) | $1.51 Billion | 34.81% | 0.30x | $277.14 Million |
| Brockhaus Technologies AG (0AAW) | $315.34 Million | 15.55% | 1.46x | $74.17 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $-10.19 Million | 0.00% | 0.00x | $71.96 Million |
| Kalray S.A. (0ABT) | $39.07 Million | -59.55% | 1.26x | $33.84 Million |